**Conflict of interest**

The authors have no relevant conflicts of interest to disclose.

#### **Funding**

No industry funding to disclose.

*Surgical Treatment Options for Obstructive Sleep Apnea DOI: http://dx.doi.org/10.5772/intechopen.91883*

*Updates in Sleep Neurology and Obstructive Sleep Apnea*

AHI of less than 20) [30].

other therapies.

**8. Conclusion**

**7. Follow up and monitoring**

patients but no complete elimination of OSA.

for recurrence or worsening of OSA.

No industry funding to disclose.

**Acknowledgements**

**Conflict of interest**

their support.

**Funding**

improved the outcome compare to single-site procedure.

now a standard procedure during the presurgical evaluation which gives the surgeon personalized anatomical information. A combination of multilevel procedures

In a meta-analysis that used 49 multilevel surgery articles showed success rate of 66.4% for mixed multilevel surgeries (reduction in the AHI of 50% or more and an

Surgical follow up is based on the type of the surgery. It should include wound management and complications. Patient also needs a long-term follow up by a sleep specialist to evaluate the need for adjunctive use of positive airway pressure or

There has been a significant improvement in the current surgical techniques for the treatment of the OSA. Surgical management is usually warranted in appropriately selected patients who could not or failed CPAP or other alternative therapies. Also, for patient with anatomical abnormalities that can be corrected. Currently DISE is very useful method and widely used to determine the levels of collapse. A comprehensive discussion between surgeon and patient prior to the surgery is warranted, discussing realistic expectations of the treatment benefits and complications. Surgical treatments showed long-term benefits in appropriately selected

Patient who undergo any surgical procedure will require long term monitoring

Huge thank you to all the staff at St. Vincent Hospital's Sleep Laboratory for all

The authors have no relevant conflicts of interest to disclose.

**182**
